Standard
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma. / Grossmann, V; Bacher, Ulrike; Artusi, V; Kohlmann, A; Nadarajah, N; Kern, W; Schnittger, S; Haferlach, T; Haferlach, C.
in:
BLOOD CANCER J, Jahrgang 2, 2012, S. 85.
Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Grossmann, V, Bacher, U, Artusi, V, Kohlmann, A, Nadarajah, N, Kern, W, Schnittger, S, Haferlach, T & Haferlach, C 2012, '
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma.',
BLOOD CANCER J, Jg. 2, S. 85. <
http://www.ncbi.nlm.nih.gov/pubmed/22941340?dopt=Citation>
APA
Grossmann, V., Bacher, U., Artusi, V., Kohlmann, A., Nadarajah, N., Kern, W., Schnittger, S., Haferlach, T., & Haferlach, C. (2012).
Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma. BLOOD CANCER J,
2, 85.
http://www.ncbi.nlm.nih.gov/pubmed/22941340?dopt=Citation
Vancouver
Bibtex
@article{e0b84f5b870f4f34ba07cf07a4ab182f,
title = "Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma.",
author = "V Grossmann and Ulrike Bacher and V Artusi and A Kohlmann and N Nadarajah and W Kern and S Schnittger and T Haferlach and C Haferlach",
year = "2012",
language = "English",
volume = "2",
pages = "85",
journal = "BLOOD CANCER J",
issn = "2044-5385",
publisher = "NATURE PUBLISHING GROUP",
}
RIS
TY - JOUR
T1 - Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma.
AU - Grossmann, V
AU - Bacher, Ulrike
AU - Artusi, V
AU - Kohlmann, A
AU - Nadarajah, N
AU - Kern, W
AU - Schnittger, S
AU - Haferlach, T
AU - Haferlach, C
PY - 2012
Y1 - 2012
M3 - SCORING: Journal article
VL - 2
SP - 85
JO - BLOOD CANCER J
JF - BLOOD CANCER J
SN - 2044-5385
ER -